Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05108974 · ClinicalTrials.gov registry record · Phase 2

Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders Study

A Phase 2 study of Fetal Alcohol Spectrum Disorders, sponsored by Jeff Wozniak.

Active
Registry status
Phase 2
Development phase
62
Enrollment target
1
Study location

NCT05108974 is a Phase 2 study of Fetal Alcohol Spectrum Disorders that is active but no longer recruiting, run by Jeff Wozniak. The registered enrollment target is 62 participants, below the 100-participant average among 10 other Fetal Alcohol Spectrum Disorders trials with a reported enrollment target (38% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05108974, a Phase 2 study of Fetal Alcohol Spectrum Disorders, is active but no longer recruiting, sponsored by Jeff Wozniak.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
62 participants
Enrollment target
1
Study location

Study Summary

This is a randomized, double-blind controlled trial of choline supplementation in children with Fetal Alcohol Spectrum Disorders (FASD). The study is comparing two administration durations (3 months vs. 6 months) of choline. The primary outcome measures are cognitive measures.

Conditions Studied

Fetal Alcohol Spectrum Disorders

Interventions

  • DRUG Choline Bitartrate

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 62 participants
Start Date 2021-10-22
Est. Completion 2026-07-31
Phase Phase 2

Sponsor

Jeff Wozniak

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05108974

The ClinicalTrials.gov registry entry for NCT05108974 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 100-participant average among 10 other Fetal Alcohol Spectrum Disorders trials with a reported enrollment target (38% lower). The listed sponsor is Jeff Wozniak, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Fetal Alcohol Spectrum Disorders appearing as the primary indexed condition, and to 1 intervention - of which Choline Bitartrate is the first listed.

NCT05108974 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT05108974 about?

NCT05108974 is a clinical study titled "Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders Study". This is a randomized, double-blind controlled trial of choline supplementation in children with Fetal Alcohol Spectrum Disorders (FASD). The study is comparing two administration durations (3 months vs. 6 months) of choline. The primary outcome measures are cognitive measures.

What is the current status of trial NCT05108974?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 62 participants. The study started on 2021-10-22. Estimated completion is 2026-07-31.

What conditions does trial NCT05108974 study?

This clinical trial studies the following conditions: Fetal Alcohol Spectrum Disorders.

What interventions are being tested in trial NCT05108974?

The interventions under investigation include: Choline Bitartrate (DRUG).

Who is sponsoring clinical trial NCT05108974?

This trial is sponsored by Jeff Wozniak, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05108974 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Fetal Alcohol Spectrum Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Fetal Alcohol Spectrum Disorders

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.